Enoxaparin dosing for venous thromboembolism prophylaxis in hospitalized underweight adult patients: a retrospective cohort study
There is no significant difference in the incidence of bleeding or VTE between the reduced dose and the standard dose of enoxaparin for VTE prophylaxis in underweight adult patients. Due to the low event rates in both groups, larger studies are required to delineate any differences between the two dosing strategies.
Authors
- May Alasmar (ORCID: https://orcid.org/0000-0002-8954-8085)
- Mohamed Saad (ORCID: https://orcid.org/0000-0002-2221-4216)
- Somaya Koraysh (ORCID: https://orcid.org/0000-0002-2743-4496)
- Faheem Butt
- Salam Ibrahim Abou Safrah
Institutions
- Hamad General Hospital (QA)
- Hamad bin Khalifa University (QA)
Publication Details
- Journal
- Thrombosis Journal
- Published
- 2025-05-07
- DOI
- https://doi.org/10.1186/s12959-025-00716-w
- Citations
- 2
- Primary Topic
- Venous Thromboembolism Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 3.74
Funders
- Hamad Medical Corporation
- Qatar National Library